CTOs on the Move

Remcore

www.remcore.com

 
Remcore is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.remcore.com
  • 7422 Carmel Executive Park Dr Ste 310
    Charlotte, NC USA 28226
  • Phone: 888.743.4700

Executives

Name Title Contact Details

Similar Companies

HistoRX

HistoRX is a Branford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ivek

Ivek Corp. is a North Springfield, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Contract Pharmacy Services

Contract Pharmacy Services is a Warrington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avanos

Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries.

Integrity Applications

Integrity Applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. Since its founding in 2001, Integrity Applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. Integrity Applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. After proof of concept in 2002, Integrity Applications developed the first working prototype, GlucoTrack in August 2003. GlucoTrack® Model DF-F received CE Mark approval in June 2013 and KFDA in March 2016. GlucoTrack is currently being marketed in the European Union and in South Korea.